Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × talquetamab × Clear all

NCT03399799 2026-04-13

MonumenTAL-1

Phase 1 Active not recruiting

279 enrolled 2 FDA

Other hematologic neoplasm

Hematologic Neoplasms